Clinical Trial Update: A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating enzalutamide for advanced hepatocellular carcinoma, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-11-20